Patient Info
The infopool
Patient Info
Prostate and you
Recently diagnosed
Understanding treatment choices
After treatment and living with prostate cancer
Our Research
21
Research Projects
Proven Connect
PCR Funding for Scientists
Research Policies
How To Support Us
Ways to Donate
Fundraise for us
Sign up to an Event
Partner with us
Leave A Gift In Your Will
Share Your Story
Pledge To Our Patient Registry
Visit our shop
About Us
What We Do
PCR in the News
Our People
Our Trustees
Jobs
Prostate Cancer Research
Funding research to increase survival and find a cure for men with advanced prostate cancer
Search
Patient Info
The infopool
Patient Info
Prostate and you
Recently diagnosed
Understanding treatment choices
After treatment and living with prostate cancer
Our Research
21
Research Projects
Proven Connect
PCR Funding for Scientists
Research Policies
How To Support Us
Ways to Donate
Fundraise for us
Sign up to an Event
Partner with us
Leave A Gift In Your Will
Share Your Story
Pledge To Our Patient Registry
Visit our shop
About Us
What We Do
PCR in the News
Our People
Our Trustees
Jobs
Donate
Search
Search
Patient Info
The infopool
Patient Info
Prostate and you
Recently diagnosed
Understanding treatment choices
After treatment and living with prostate cancer
Our Research
21
Research Projects
Proven Connect
PCR Funding for Scientists
Research Policies
How To Support Us
Ways to Donate
Fundraise for us
Sign up to an Event
Partner with us
Leave A Gift In Your Will
Share Your Story
Pledge To Our Patient Registry
Visit our shop
About Us
What We Do
PCR in the News
Our People
Our Trustees
Jobs
Donate
Search
Prostate Cancer Research
News Centre
Research Updates
Research Updates
Government announces major prostate cancer screening trial to end needless prostate deaths
21 November 2023
Government announces major prostate cancer screening trial to end needless prostate deaths
Research Updates
Pluvicto™ Update
30 October 2023
Pluvicto™ Update
Research Updates
Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland
9 October 2023
Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland
Research Updates
Exploring men’s psychological adjustment to prostate cancer
8 August 2023
Exploring men’s psychological adjustment to prostate cancer
Research Updates
NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer
18 May 2023
NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer
Research Updates
#GiveMenMoreTime – NICE reopens consultation on Pluvicto
2 March 2023
#GiveMenMoreTime – NICE reopens consultation on Pluvicto
All
,
PCR News
,
Research Updates
Predicting which cancers will return
24 February 2023
Predicting which cancers will return
Research Updates
TOPiC: Talking with men about treatment Options for Prostatic Cancer
15 December 2022
TOPiC: Talking with men about treatment Options for Prostatic Cancer
PCR News
,
Research Updates
Unlocking Prostate Cancer Data
7 December 2022
Unlocking Prostate Cancer Data
Research Updates
NICE consults on provisional decision to block NHS access to Pluvicto® (lutetium (177Lu) vipivotide tetraxetan) radioligand therapy for advanced prostate cancer
17 October 2022
NICE consults on provisional decision to block NHS access to Pluvicto® (lutetium (177Lu) vipivotide tetraxetan) radioligand therapy for advanced prostate cancer
Research Updates
Thousands of men likely to benefit from new drug which extends life
12 August 2022
Thousands of men likely to benefit from new drug which extends life
Research Updates
Government commits £260 million to boost NHS-led research
2 March 2022
Government commits £260 million to boost NHS-led research
Load more